Seoul, South Korea

Kook Jin Kang

This inventor holds 1 USPTO granted patent. Top assignee: Alpinion Medical Systems Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kook Jin Kang. Retrieved from https://idiyas.com/inventor/kook-jin-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kook Jin Kang and Ultrasonic Cavitation Control

Introduction

Kook Jin Kang is an inventor associated with Seoul, South Korea, and Alpinion Medical Systems Co., Ltd. His patent work focuses on controlling cavitation bubbles with ultrasonic signals.

Latest Patents

Kang is credited with 1 patent: “Ultrasonic Signal Generation Method for Cavitation Bubble Control and Ultrasonic Treatment Device Using Same.” The invention describes determining transmission ratios for first- and second-frequency ultrasonic signals. The first signal is directed toward a target area to expand a cavitation bubble, while the second signal is used to stop its expansion.

Career Highlights

Kang’s listed work connects him with Alpinion Medical Systems Co., Ltd., a company involved in medical systems. His patent addresses the controlled use of ultrasonic signals in an ultrasonic treatment device.

Collaborations

Kang’s listed coworkers include Won Seok Lee and Hyeon Peel Choi. Their names are associated with the professional context provided for his work.

Conclusion

Kook Jin Kang’s patent highlights an approach to managing cavitation bubble expansion through coordinated ultrasonic signals, reflecting his contribution to invention in the medical systems field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…